genedrive plc is a United Kingdom-based pharmacogenetic testing company. The Company is engaged in developing and commercializing a rapid, versatile, simple to use and robust point-of-need pharmacogenetic platform for the diagnosis of genetic variations. The Company’s products include Genedrive MT-RNR1 ID Kit, Genedrive System, and Genedrive CYP2C19 ID Kit. The Company’s flagship product Genedrive MT-RNR1 ID Kit is a single-use disposable cartridge that circumvents the requirement for cold chain logistics by providing temperature stable reagent test kits for use on their proprietary test platform. The Genedrive System is a rapid thermocycler and signal detection system, enabling PCR and isothermal based amplification techniques. It is a semi- automated system used for qualitative in vitro molecular diagnostic tests. Its Genedrive CYP2C19 ID Kit Molecular point-of-care test for rapid CYP2C19 genotyping in time-critical emergency care settings.
Back to dashboard
Company Information
About this company
Key people
Graham Cole
Non-Executive Independent Chairman of the Board
Gino Miele
Chief Executive Officer, Chief Scientific Officer, Executive Director
Russell Shaw
Chief Financial Officer, Executive Director, Company Secretary
Tom Lindsay
Non-Executive Director
David Nugent
Non-Executive Director
Christopher Henry Francis Yates
Non-Executive Director
Click to see more
Key facts
- Shares in issue1.61bn
- EPICGDR
- ISINGB00B1VKB244
- LocationUnited Kingdom
- SectorTechnology
- IndustryScientific & Technical Instr.
- Market cap£19.27m
- Employees43
- ExchangeLondon Stock Exchange (LON)
- Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.